Satoshi Kazuma
Overview
Explore the profile of Satoshi Kazuma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tatsumi H, Chihara S, Akatsuka M, Kuroda H, Kazuma S, Tani M, et al.
J Ren Nutr
. 2025 Mar;
PMID: 40024388
Objective: Amino acid and protein loss during continuous renal replacement therapy (CRRT) has been proposed to contribute to protein energy wasting (PEW) in patients with acute kidney injury (AKI); however,...
2.
Kudo M, Chihara S, Tatsumi H, Kazuma S, Masuda Y
Cureus
. 2025 Feb;
17(1):e77500.
PMID: 39958120
In Japan, the post-dilution method is preferred to maintain the dialysis efficiency of low molecular weight substances in continuous hemodiafiltration (CHDF). In contrast, the pre-dilution method is preferable to ensure...
3.
Tanaka S, Haruna J, Kazuma S, Tatsumi H, Masuda Y
Anaesth Intensive Care
. 2025 Jan;
53(2):125-135.
PMID: 39866022
Polymyxin B haemoperfusion is commonly used to adsorb endotoxins in septic shock caused by Gram-negative bacterial infections. Polymyxin B haemoperfusion has been reported to improve hypotension in Gram-positive bacterial infections;...
4.
Kikuchi K, Kazuma S, Masuda Y
Diagnostics (Basel)
. 2024 Sep;
14(18).
PMID: 39335761
Background/objectives: Hyperlactatemia is a common predictive factor for poor post-cardiovascular surgery outcomes. However, it is not well understood whether the rapid postoperative lactate level elevation in a short period of...
5.
Kikuchi K, Kazuma S, Yamakage M
Respir Res
. 2024 Sep;
25(1):330.
PMID: 39227918
Background: Vascular endothelial damage is involved in the development and exacerbation of ventilator-induced lung injury (VILI). Pulmonary endothelial glycocalyx and neutrophil extracellular traps (NETs) are endothelial protective and damaging factors,...
6.
Chihara S, Ishigo T, Kazuma S, Matsumoto K, Morita K, Masuda Y
Antibiotics (Basel)
. 2024 Aug;
13(8).
PMID: 39200055
Aggressive pharmacokinetic (PK)/pharmacodynamic (PD) targets have shown better microbiological eradication rates and a lower propensity to develop resistant strains than conservative targets. We investigated whether meropenem blood levels, including aggressive...
7.
Tatsumi H, Akatsuka M, Kuroda H, Kazuma S, Masuda Y
Cureus
. 2024 Jul;
16(6):e63103.
PMID: 39055443
Background: Since severe acute pancreatitis (SAP) involves inflammatory mediators produced by local inflammation of the pancreas that trigger a systemic inflammatory response, intensive fluid management is required to maintain hemodynamics...
8.
Satoh K, Wada T, Tampo A, Takahashi G, Hoshino K, Matsumoto H, et al.
Thromb J
. 2024 Jul;
22(1):67.
PMID: 39039520
Thrombocytopenia frequently occurs in patients with sepsis. Disseminated intravascular coagulation (DIC) may be a possible cause of thrombocytopenia owing to its high prevalence and association with poor outcomes; however, it...
9.
Kikuchi K, Kazuma S, Masuda Y
Cureus
. 2024 Apr;
16(3):e57118.
PMID: 38681321
Background: Although mortality due to sepsis has decreased in recent decades, there are few studies on the timing of death during ICU stay. Characteristics of patients related to changes over...
10.
Tatsumi H, Akatsuka M, Kuroda H, Kazuma S, Suzuki S, Masuda Y
PLoS One
. 2023 Jun;
18(6):e0286088.
PMID: 37384758
Introduction: Linezolid (LZD) is one of the antibiotics used to treat methicillin-resistant Staphylococcus aureus. In Japan, the dose of LZD is not generally adjusted by renal function or therapeutic drug...